Azacitadine
1 abstract
Abstract
Olutasidenib in post-venetoclax patients with mIDH1 AML.Org: Georgia Cancer Center, Augusta University, Medical College of Georgia at Augusta University, Augusta, GA, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA,